These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27572707)

  • 41. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, molecular modeling and evaluation of α-glucosidase inhibition activity of 3,4-dihydroxy piperidines.
    Kasturi SP; Surarapu S; Uppalanchi S; Dwivedi S; Yogeeswari P; Sigalapalli DK; Bathini NB; Ethiraj KS; Anireddy JS
    Eur J Med Chem; 2018 Apr; 150():39-52. PubMed ID: 29518717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Catalytic asymmetric synthesis of indole derivatives as novel α-glucosidase inhibitors in vitro.
    Islam MS; Barakat A; Al-Majid AM; Ali M; Yousuf S; Iqbal Choudhary M; Khalil R; Ul-Haq Z
    Bioorg Chem; 2018 Sep; 79():350-354. PubMed ID: 29807208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
    Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents.
    Acar Çevik U; Celik I; Paşayeva L; Fatullayev H; Bostancı HE; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200663. PubMed ID: 36760015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
    Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.
    Moghadam Farid S; Noori M; Nazari Montazer M; Khalili Ghomi M; Mollazadeh M; Dastyafteh N; Irajie C; Zomorodian K; Mirfazli SS; Mojtabavi S; Faramarzi MA; Larijani B; Iraji A; Mahdavi M
    Sci Rep; 2023 Mar; 13(1):4392. PubMed ID: 36928433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors.
    Zhen J; Dai Y; Villani T; Giurleo D; Simon JE; Wu Q
    Bioorg Med Chem; 2017 Oct; 25(20):5355-5364. PubMed ID: 28797772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple and efficient synthesis of benzimidazoles containing piperazine or morpholine skeleton at C-6 position as glucosidase inhibitors with antioxidant activity.
    Özil M; Parlak C; Baltaş N
    Bioorg Chem; 2018 Feb; 76():468-477. PubMed ID: 29287256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives.
    Khan KM; Qurban S; Salar U; Taha M; Hussain S; Perveen S; Hameed A; Ismail NH; Riaz M; Wadood A
    Bioorg Chem; 2016 Oct; 68():245-58. PubMed ID: 27592296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of potent α-glucosidase inhibitor flavonols: Insights into mechanism of action through inhibition kinetics and docking simulations.
    Şöhretoğlu D; Sari S; Barut B; Özel A
    Bioorg Chem; 2018 Sep; 79():257-264. PubMed ID: 29778797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
    Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
    Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of α-glucosidase inhibiting potentials with docking calculations of synthesized arylidene-pyrazolones.
    Chaudhry F; Naureen S; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Jahan B; Hyder Khan M; Iqbal F; Ali Munawar M; Ain Khan M
    Bioorg Chem; 2018 Apr; 77():507-514. PubMed ID: 29454828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitro-substituted tetrahydroindolizines and homologs: Design, kinetics, and mechanism of α-glucosidase inhibition.
    Tavani C; Bianchi L; De Palma A; Passeri GI; Punzi G; Pierri CL; Lovece A; Cavalluzzi MM; Franchini C; Lentini G; Petrillo G
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3980-3986. PubMed ID: 28781158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors.
    Taha M; Imran S; Rahim F; Wadood A; Khan KM
    Bioorg Chem; 2018 Feb; 76():273-280. PubMed ID: 29223804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors.
    Khan IA; Ahmad M; Ashfaq UA; Sultan S; Zaki MEA
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanistic investigation of anthocyanidin derivatives as α-glucosidase inhibitors.
    Kim JH; Kim HY; Jin CH
    Bioorg Chem; 2019 Jun; 87():803-809. PubMed ID: 30978605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.